দেশ: কানাডা
ভাষা: ইংরেজি
সূত্র: Health Canada
PERINDOPRIL ERBUMINE
BIOMED PHARMA
C09AA04
PERINDOPRIL
8MG
TABLET
PERINDOPRIL ERBUMINE 8MG
ORAL
15G/50G
Prescription
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS
Active ingredient group (AIG) number: 0127178003; AHFS:
APPROVED
2020-07-08
1 PRODUCT MONOGRAPH PR BIO-PERINDOPRIL PERINDOPRIL ERBUMINE TABLETS, USP 2 MG, 4 MG AND 8 MG ANGIOTENSIN CONVERTING ENZYME INHIBITOR BIOMED PHARMA JULY 7, 2020 DATE OF REVISION: SUBMISSION CONTROL NO.: 239989 H1P 3H8, CANADA MONTREAL, QUEBEC 1B-9450 BOUL. LANGELIER 2 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ...........................................................................3 SUMMARY PRODUCT INFORMATION ..................................................................................................3 INDICATIONS AND CLINICAL USE ........................................................................................................3 CONTRAINDICATIONS ............................................................................................................................. 4 WARNINGS AND PRECAUTIONS ............................................................................................................5 ADVERSE REACTIONS ............................................................................................................................ 14 DRUG INTERACTIONS ............................................................................................................................ 22 DOSAGE AND ADMINISTRATION ........................................................................................................25 OVERDOSAGE .......................................................................................................................................... 28 ACTION AND CLINICAL PHARMACOLOGY ......................................................................................28 STORAGE AND STABILITY .................................................................................................................... 32 SPECIAL HANDLING INSTRUCTIONS .................................................................................................32 DOSAGE FORMS, COMPOSITION AND PACKAGING ........................................................................32 PART II: SCIEN সম্পূর্ণ নথি পড়ুন